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Abstract
Background: Severe post tracheostomy (PT) and post intubation (PI) tracheal stenosis is an
uncommon clinical entity that often requires interventional bronchoscopy before surgery is
considered. We present our experience with severe PI and PT stenosis in regards to patient
characteristics, possible risk factors, and therapy.
Methods: We conducted a retrospective chart review of 31 patients with PI and PT stenosis
treated at Lahey Clinic over the past 8 years. Demographic characteristics, body mass index, co-
morbidities, stenosis type and site, procedures performed and local treatments applied were
recorded.
Results: The most common profile of a patient with tracheal stenosis in our series was a female
(75%), obese (66%) patient with a history of diabetes mellitus (35.4%), hypertension (51.6%), and
cardiovascular disease (45.1%), who was a current smoker (38.7%). Eleven patients (PI group) had
only oro-tracheal intubation (5.2 days of intubation) and developed web-like stenosis at the cuff
site. Twenty patients (PT group) had undergone tracheostomy (54.5 days of intubation) and in 17
(85%) of them the stenosis appeared around the tracheal stoma. There was an average of 2.4
procedures performed per patient. Rigid bronchoscopy with Nd:YAG laser and dilatation
(mechanical or balloon) were the preferred methods used. Only 1(3.2%) patient was sent to
surgery for re-stenosis after multiple interventional bronchoscopy treatments.
Conclusion: We have identified putative risk factors for the development of PI and PT stenosis.
Differences in lesions characteristics and stenosis site were noted in our two patient groups. All
patients underwent interventional bronchoscopy procedures as the first-line, and frequently the
only treatment approach.
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Background
Post intubation (PI) tracheal stenosis was first recognized
as an entity in 1880, after MacEwen instituted prolonged
endotracheal intubation in four patients with upper air-
way obstruction[1]. Since then PI stenosis and later post
tracheostomy (PT) stenosis has been rare but serious com-
plications although the degree of tracheal stenosis may
vary. Among all intubated patients, the reported incidence
of PI and PT stenosis ranges from 10 to 22% [2-6] but only
1–2% of the patients are symptomatic or have severe ste-
nosis [7-9]. Today, severe PI and PT stenosis are recog-
nized entities with an estimated incidence of 4.9 cases per
million per year in the general population [10].
Prolonged intubation can result in tracheal stenosis at var-
ious levels within the trachea[11]. Stenosis can occur any-
where from the level of the endotracheal tube tip up to the
glottic and subglottic area, but the most common sites are
where the endotracheal tube cuff has been in contact with
the tracheal wall and at the tracheal stoma site after a tra-
cheostomy procedure. Thus, tracheal stenosis can most
commonly occur following the two types of airway intu-
bation: endotracheal intubation (PI) and tracheostomy
(PT).
Tracheal stenosis occurs at the endotracheal tube cuff site
in one third of the reported PI cases[4,5,12] and appears
as a web-like fibrous growth. The mainly postulated caus-
ative factor is loss of regional blood flow due to cuff pres-
sure on the tracheal wall[13]. This ischemic injury begins
within the first few hours of intubation, and healing of the
damaged region can result in web-like fibrosis within 3 to
6 weeks[13,14]. Fortunately the advent of large volume,
low pressure cuffs has markedly reduced the occurrence of
cuff injury[6,15,16].
In contrast, tracheal stenosis following tracheostomy
most commonly results from abnormal wound healing
with excess granulation tissue formation around the tra-
cheal stoma site; excess granulation tissue can also
develop over a fractured cartilage, which can occur during
the tracheostomy procedure[4,5,12,17]. Cartilage damage
may also result from mechanical leverage of the tracheal
tube at the stoma site due to the unsupported weight of
ventilator attachments, causing pressure necrosis. In a
recent review paper by Sarper et al. wound sepsis was also
found as a causative factor in 42% of the stoma stenosis
cases following open tracheostomy[18].
Multiple other factors predisposing to the development of
PI and PT stenosis have been suggested, including: high
tracheostomy site, prolonged intubation period, trau-
matic intubation, history of previous intubation or previ-
ous tracheostomy, excessive corticosteroid steroid usage,
advanced age, female and estrogen effect, severe respira-
tory failure, severe reflux disease, autoimmune diseases
(Wegener's granulomatosis, sarcoidosis and others),
obstructive sleep apnea, and radiation therapy for oropha-
ryngeal and laryngeal cancer[2,19].
In the past, tracheal stenosis was managed with dilatation
alone[20,21], and success was measured by the ability to
wean patients from their tracheostomy tubes. Until
recently, surgical resection and end to end anastomosis
was considered the only definitive treatment for tracheal
stenosis[14,22]. Grillo and Mathisen[23] have reported
low (1.8%) mortality rates associated with surgical inter-
vention but others have reported mortality rates up to 5%
[24,25]. Interventional bronchoscopy procedures can
serve as a bridge to surgical treatment but most impor-
tantly, can constitute definitive therapy for many patients,
including these that are surgical candidates[24]. Previous
studies have reported variable success rates of interven-
tional bronchoscopy procedures, ranging from 32[26] to
66%[27].
As an institution with a long experience in interventional
bronchoscopy procedures, we felt it would be valuable to
review our approach to the management of PI and PT ste-
nosis. In this paper, we present the characteristics of
patients with PI and PT stenosis treated at Lahey Clinic
over the past 8 years, and review the treatment strategies
used. Putative risk factors for the development of PI and
PT stenosis are identified and discussed.
Methods
Our institution serves as a regional referral center for inter-
ventional bronchoscopy procedures. We conducted a ret-
rospective review of all patients who were referred to the
interventional pulmonology service, department of pul-
monary and critical care at Lahey clinic, Burlington, Mas-
sachusetts for evaluation and management of PI and PT
stenosis. The study was approved by the Institutional
Review Board.
Patients were identified from the prospectively main-
tained bronchoscopy suite and operation room logbooks.
A total of 31 patients were identified between January
1999 and January 2007. Twenty patients were treated for
tracheal stenosis following tracheostomy (PT group) and
11 patients were treated for tracheal stenosis developing
after prolonged endotracheal intubation (PI group).
Demographic data was obtained for each patient: age, sex,
body mass index (BMI), co-morbid conditions and corti-
costeroid therapy received. The following data regarding
the tracheal stenosis were also obtained: the circum-
stances leading to the development of tracheal stenosis
(PI versus PT), type of stenosis (web-like stenosis, granu-
lation tissue formation, tracheomalacia) and the thera-
peutic interventional pulmonary procedure(s) performed.BMC Pulmonary Medicine 2008, 8:18 http://www.biomedcentral.com/1471-2466/8/18
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Each patient underwent a standard pre-operative assess-
ment, including physical examination, routine laboratory
tests, chest radiography and computed tomography of the
chest. An initial diagnostic flexible bronchoscopy (FB)
was performed for each patient to identify the type, loca-
tion and severity of the stenosis. The stenosis was charac-
terized severe if it was causing symptoms, primarily
dyspnea, was complex in nature (stenosis combined with
cartilage fracture or tracheomalacia) and the obstruction
of the tracheal lumen exceeded 50%. The degree of steno-
sis was estimated with a dedicated instrument that was
used to measure the diameter of the stenotic area and the
diameter of the trachea lumen before and after the sten-
otic site. In some later cases the stenosis was estimated by
virtual bronchoscopy along with the dedicated measuring
device.
Rigid bronchoscopy (RB) was performed under general
anesthesia in an operating room, while therapeutic FB was
performed under moderate sedation with midazolam and
fentanyl, in the bronchoscopy suite. The equipment used
included the Dumon Series II rigid broncoscopes (Bryan
Corporation Inc. Woburn, MA, USA) with optical system,
stent introducer and forceps, and flexible bronchoscopes
(Pentax Co. Tokyo, Japan or Olympus Co. Tokyo, Japan).
Multiple therapeutic modalities were used including
mechanical debulking and dilatation with the RB, balloon
dilatation, Neodymium-Doped Yttrium Aluminium Gar-
net (Nd:YAG) laser photocoagulation, stent placement,
electrocautery, and argon plasma coagulation (APC). Dur-
ing laser, APC and electrocautery treatment the FiO2 was
adjusted to 30–40% to avoid the complication of endo-
bronchial fire and burn.
For web-like stenoses a recommended mucosal sparring
technique with radial incisions followed by airway dilata-
tion was applied [27]. For stenosis produced by granula-
tion tissue formation around the tracheal stoma, RB and
photocoagulation with Nd:YAG laser was mostly used. As
an alternative, electrocautery or APC was used under FB in
some patients. Damaged cartilage and the remaining
granulation tissue were removed by grasping forceps.
Stent implantation was used more commonly in patients
with tracheomalacia and in patients with recurrent steno-
sis. Mixed stenosis was treated with more than one thera-
peutic modality.
Patients were considered cured when free of symptoms for
at least one year after the initial intervention (the last
treated patient was followed for 11 months). If re-stenosis
was occurred on a follow up bronchoscopy (usually every
4 to 6 weeks for the first 6 months) then another interven-
tion was applied. In most cases no more than 3 interven-
tions were needed.
Numerical data are presented as means and standard devi-
ation (or median and range) and were compared using
the Student's t-test or the Mann-Whitney U-test when nor-
mality failed. Patient follow-up extended until November
2007. The statistics were computed with SPSS statistical
software (SPSS version 14 for Windows; SPSS; Chicago,
IL, USA).
Results
PI and PT group characteristics are presented in Table 1.
The patient population included 20 obese patients (some
of them morbidly obese), raising the mean body mass







Age (median-range) 58.2 (28–86) 50.2 (21–76)
Body Mass Index (mean ± SD) 34.1 ± 8.9 32.3 ± 9.6
Diabetes mellitus 8 (40%) 3 (27%)
Cardiovascular disease 9 (45%) 5 (45%)
Coronary Artery Bypass Graft 3 (15%) 2 (18%)
Systemic Hypertension 11 (55%) 5 (45%)
Gastro Esophageal Reflux Disease 6 (30%) 2 (18%)
Chronic Obstructive Pulmonary Disease 3 (15%) 2 (18%)
Asthma 2 (10%) 2 (18%)
Obstructive sleep apnea 3 (15%) 0
Hypothyroidsm 3 (15%) 0
Alcohol 4 (20%) 2 (18%)
Smoking 7 (35%) 5 (45%)
Corticosteroid therapy 2 (10%) 2 (18%)
*female predominance is seen in both groups, PI: post intubation, PT: post tracheostomy, SD: standard deviation.BMC Pulmonary Medicine 2008, 8:18 http://www.biomedcentral.com/1471-2466/8/18
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index above 30 in both groups. Patients were predomi-
nantly female in both groups. The most frequent co-mor-
bidities were diabetes mellitus, cardiovascular disease,
hypertension and gastro-esophageal reflux disease. One
third of the patients were current smokers.
The characteristics of the tracheal stenosis varied depend-
ing on whether the development of tracheal stenosis fol-
lowed post intubation or tracheostomy, and are presented
in table 2. The mean length of the stenosis was greater in
the PI group due to the (common) formation of a web-
like stenosis along the distribution of the endotracheal
tube cuff. Patients with PI stenosis had a mean duration of
intubation of 5.2 days. Not surprisingly, patients with tra-
cheal stenosis following tracheostomy had a much longer
duration of cannulation, with a mean of 54.5 days.
The types of the tracheal stenoses developing in the PT
and PI groups are presented in Figures 1 and 2. The most
common type of stenosis was granulation tissue forma-
tion at the stoma site in the PT group, and web-like fibro-
sis in the PI group. No significant difference was noted
between males and females with regards to the predispos-
ing factors or co-morbid conditions, and the type of tra-
cheal stenosis (PI ot PT).
The treatment modalities used are presented in Table 3.
RB was the most commonly utilized procedure to
approach the airway with tracheal stenosis. Mechanical
debulking and dilatation with the RB, balloon dilatation,
Nd:YAG laser therapy and stent placement were the most
common interventional procedures employed.
Each patient underwent an average of 2 procedures during
their treatment course. Most of the patients underwent 1
to 4 procedures; two patients were treated with 5 proce-
dures and a single patient who was eventually sent to sur-
gery underwent a total of 17 procedures. This patient was
sent to surgery because of recurrent tracheal stenosis after
multiple treatments with rigid bronchoscopy, Nd:YAG
laser and repeated silicone stent implantations over a six-
year period. This patient was a female, obese patient (BMI:
33.4) who developed tracheal stenosis after 4 days of
endotracheal intubation for MRSA pneumonia. She had
multiple risk factors including sickle cell anemia, diabetes
mellitus and asthma and was receiving 30 mg po daily of
prednisone.
Eight patients (26%) developed recurrent tracheal steno-
sis after the first bronchoscopic intervention, with 7 of
them being females. No correlation was found between
the tendency to develop re-stenosis and the type of the ste-
nosis (PI or PT), the potential risk factors identified, or the
treatment modality used.
Discussion
In this study, we have reviewed the patient characteristics
and endoscopic treatments performed in a series of indi-
viduals who developed tracheal stenosis following
endotracheal intubation or tracheostomy. Our study
results show the similarities of characteristics among the
two patient groups and point out the differences in the
stenosis type/site and treatments applied between them.
An important limitation is the lack of a control group that
would have allows us to estimate more accurate the risk
factors and patients characteristics that lead to tracheal
stenosis. The reason for difficulty selecting an appropriate
control group is the fact that our patients were referred to
us from different hospitals or even from different states,
so we were not able to find a control group of patients that
would resemble our patients' characteristics.
Our paper differs from others published in the literature
regarding patients' profile. The typical profile of a patient
with PI or PT stenosis that emerged from our data is a
female obese patient with past medical history of diabetes
mellitus, hypertension, and cardiovascular disease, who
was a current smoker. The gender influence has been con-
troversial in the literature. A predominance of female with
tracheal stenosis has been reported in two series by
McCaffrey et al[28] and Mehta et al[27] respectively.
Female predominance is also reported in cases of idio-
pathic subglottic stenosis[19,29,30]. It has been postu-
lated that estrogens increase the levels of transforming
growth factor β1 promoting extracellular matrix produc-
tion, including the deposition of type I and III collagens
Table 2: Characteristics of the tracheal stenosis regarding days of intubation, the exact site and degree of the stenosis.
PT group (20 patients) 
(mean-range)
PI group (11 patients) 
(mean-range)
Days with ETT 5.5 (4–7) 5.2 (2–10)
Days with tracheostomy 54.5 (14–151) -
Distance from vocal cords (cm) 3.1 (2–7) 2.7 (1–5)
Distance from main carina (cm) 5.5 (5–6) 5.5 (3–8)
Length of stenosis (cm) 1.2 (0.5–2.5) 2.6 (0.5–7)
Percent of tracheal stenosis 78.5% (60–90%) 71% (50%–90%)
ETT: endotracheal tube, pts: patients, PI: post intubation, PT: post tracheostomy.BMC Pulmonary Medicine 2008, 8:18 http://www.biomedcentral.com/1471-2466/8/18
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and finally fibrosis. Whether this mechanism could con-
tribute to the female predominance noted in our cases of
tracheal stenosis is unclear.
All of our patients had severe (>50%) tracheal stenosis
with an average degree of stenosis of more than 70%.
Severe tracheal stenosis prevalence should be very low [7-
9] especially since the introduction of large volume, low
pressure endotracheal tube cuffs, the careful placement of
the tracheostomy stoma, avoidance of large apertures,
elimination of heavy ventilatory connecting equipment,
and meticulous care of the tracheostomy[6,15,16]. A
study by Norwood et al[31] who followed 48 patients for
30 months after percutaneous tracheostomy using tra-
cheal CT scans found that only 1 patient (2%) developed
severe tracheal stenosis, while mild to moderate stenosis
was detected in 14 (29.3%) patients. Our series reflects a
large referral network and does not necessarily reflect the
true prevalence of the condition.
The site of the stenosis varies according to whether the
patient has had tracheostomy or only endotracheal intu-
bation. Patients with PI stenosis tend to develop web-like
fibrous stenosis at the cuff site while tracheostomy
patients develop stenosis due to granulation tissue around
the stoma site, and frequently there is an associated carti-
lage fracture or malacia of the trachea wall. Also patients
in the tracheostomy group were intubated for longer peri-
ods, thus exposing them to more trauma at the tracheal
stoma site, and risk of infection. The mean length of the
web-like tracheal stenosis lesion (2.6 cm) in the PI group
is in accordance with the results of other case
series[28,32,33]. The length of stenosis in the PT group
was only 1.2 cm. Stenosis that developed as a web around
an endotracheal tube cuff is longer and more uniform
than the stenosis around a tracheal stoma where granula-
tion tissue can extent from a fissure in the anterior trachea
or grow into a bulky granulomatus formation surround-
ing a fracture cartilage.
Obesity was mentioned as a coexisting underlying condi-
tion in 14% of the cases described by Cavaliere at al[34].
No studies in the literature have previously correlated
obesity with the risk of developing tracheal stenosis. The
rate of obesity (66%) in our case series exceeds the
National Health and Nutrition Examination Survey prev-
alence of obesity in adults, which was estimated at 32% in
2004 [35-37]. Obesity correlates also with an increased
Site and type of the stenosis in the post tracheostomy group Figure 1
Site and type of the stenosis in the post tracheostomy group.BMC Pulmonary Medicine 2008, 8:18 http://www.biomedcentral.com/1471-2466/8/18
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neck circumference that poses a higher risk of trauma and
cartilage fracture during a tracheostomy procedure.
Diabetes mellitus prevalence in patients with PI or PT
stensois ranges from 10 to 23% in several case
series[19,24,34] while cardiovascular disease ranges from
Site and type of the stenosis in the post intubation group Figure 2
Site and type of the stenosis in the post intubation group.
Table 3: A variety of modalities and treatments applied in both groups with the use of rigid as well as the flexible bronchoscopes.
PT group 
(n = 20)
Number of procedures PI group 
(n = 11)
Number of procedures
RB and FB (mean and range) 20 41 (2.1, 1–5) 11 36 (3.2, 1–17)
Surgery 0 0 1 1
Nd:YAG Laser 8 9 6 14
Electrocautery 5 7 0 0
APC 1 1 2 2
Balloon dilatation 6 8 3 3
Cryotherapy 1 1 1 1
Stent 11 15 6 11
Montgomery tube 2 2 0 0
Mechanical debulking/dilation 5 5 6 7
APC: Argon Plasma Coagulation, Nd:YAG: Neodymium-Doped Yttrium Aluminium Garnet, PI: Post Intubation, PT: Post Tracheostomy. RB: Rigid 
bronchoscopy, FB: Flexible bronchoscopy.BMC Pulmonary Medicine 2008, 8:18 http://www.biomedcentral.com/1471-2466/8/18
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17.5 to 46%[24,32,34]. In our patient groups diabetes
mellitus and cardiovascular disease appear as co-morbid-
ities in at least one out of three patients. Patients with dia-
betes mellitus and/or cardiovascular disease may have
microvascular occlusion that contributes to the regional
ischemia caused by the endotracheal tube cuff pres-
sure[14]. The same effect of regional ischemia might be
expected during situations of low perfusion pressure such
as cardiopulmonary bypass[14]. In our study 5 patients
(16%) developed tracheal stenosis after cardiopulmonary
bypass surgery.
Smoking history have been suggested as potential risk fac-
tor by Koshkareva et al[19] but other studies have shown
no significant correlation with the risk of developing tra-
cheal stenosis[18,33,34].
In our patients corticosteroids equivalent to 10–50 mg
prednisone treatment for co-morbidities such as idio-
pathic pulmonary fibrosis (IPF), cryptogenic organizing
pneumonia (COP) or sickle cell anemia was recorded in 4
(12.9%) patients. Steroids, because of their effect on
wound healing, have been reported as a predisposing fac-
tor for the development of tracheal stenosis. This observa-
tion, however, has not been universally accepted[2].
Seven (22.5%) of our patients had a history of reflux dis-
ease, which has previously been reported only as a risk fac-
tor for idiopathic subglottic stenosis[38,39].
The management of patients with PI or PT stenosis varies
according to the location of the damage, the severity of the
stenosis, the initial airway injury trigger (endotracheal
tube vs tracheostomy), the subsequent stenosis type and
the presence of co-morbid conditions. Our treatment
approach was different between the two groups. Web-like
stenosis in PI patients was treated with radial incisions
(laser, electrocautery or APC) and dilatation. Cartilage
fracture in the anterior tracheal wall after a tracheostomy
procedure was most likely to happen in patients with cal-
cified cartilage rings and was visible as a white cartilagi-
nous material protruding into the tracheal lumen.
Granulation tissue and/or damaged cartilage in PT
patients was mainly photocoagulated by Nd:YAG laser
during a rigid bronchoscopy procedure and removed with
the use of biopsy forceps. In some cases, APC and electro-
cautery modalities were used under flexible bronchoscopy
procedure and this is also the approach followed and
described in several other articles for granulation tissue
removal[24,40]. Stent implantation was used as a last
therapeutic resort in both patient groups. Several rigid
bronchoscopy and/or flexible bronchoscopy procedures
were often required to achieve optimal results. One
patient underwent 17 rigid bronchoscopies and was ulti-
mately sent to surgery. Our general approach is to manage
PI and PT stenosis non-surgically, and reserve the surgical
option for recurrent and refractory cases. Surgery is not
always feasible, because of co-morbidities and poor per-
formance status[24]. Brichet et al[24] described their
multidisciplinary approach for post intubation tracheal
stenosis, and reported that surgery was required in only 2
patients (8%) with web stenosis and 2 patients (13%)
with complex stenosis.
Re-stenosis at the site of the intervention (as a result of an
abnormal healing process) or a stent "event" (obstruction,
migration or halitosis) were the most common reasons of
a multiple procedure. The mean number of treatments
provided to our patients (2.1 in PT group – 3.2 in PI
group) is higher than that reported by others (1.5–1.7
treatments) [19,27]. (The fact that our patient underwent
17 procedures has skewed our results. If this patient were
excluded from the analysis the mean number of proce-
dures performed would have dropped to 1.9 for the PI
group.)
In regard to therapy most prior reports on this subject
combine these two patient groups because treatment is
similar and relies on interventional bronchoscopy proce-
dures or surgery. We postulate that the etiology, patho-
genesis and treatment approach of the stenoses differ
significantly between the PT and PI group.
In comparison with other series our study highlights the
differences in patient characteristics and treatments
approach between the two types of stenoses. Due to the
rarity of tracheal stenosis, all case series report a small
number of patients often with characteristics that differ
between institutes. Although there is no uniform treat-
ment approach to these patients, most centers tend to rely
on surgery for the treatment of the stenosis. The interven-
tional bronchoscopy is relatively new and now evolving.
Although surgery is a definitive treatment, patients with
co-morbidities and poor performance status may not be
eligible for this option. Mortality rates after end to end
anastomosis can be seen up to 5% [24,25] along with
complications such as re-stenosis, suture granuloma for-
mation, infections, hemorrhage, subcutaneous emphy-
sema and others[41,42]. As we have already mentioned
co-morbidities are almost always present in PI and PT
patients and thus interventional bronchoscopy proce-
dures may be the only available option.
Conclusion
Tracheal stenosis after endotracheal intubation and tra-
cheal stenosis after tracheostomy differ in etiology and
pathogenesis and should be considered as two different
entities.BMC Pulmonary Medicine 2008, 8:18 http://www.biomedcentral.com/1471-2466/8/18
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Interventional bronchoscopy should be the first approach
in the treatment sequence of these patients, and may be
the only required treatment in the majority of patients.
Prospective carefully designed controlled studies are
needed to better define the role of predisposing factors
and co-morbidities in determining appropriate treatment
for tracheal stenosis.
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